Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Cancer Prev Res (Phila). 2019 Apr 9;12(6):391–400. doi: 10.1158/1940-6207.CAPR-18-0377

Figure 1:

Figure 1:

Comparison of multiplex immunoassays for CA125, HE4, MMP-7 and CA72-4 against ELISA methods utilizing early stage ovarian cancer patient samples show good correlation between methods.